BBP Among Health Care ETFs
End-of-day Nov 19, 2026 · 39 Health care ETFs by Max
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | −1.1% | −5.4% | −7.6% | −9.8% | +21.3% | +24.3% | +97.1% | +90.9% | +187.9% | +277.8% |
| Peer average | −1.5% | −5.1% | −2.8% | −5.1% | +15.0% | +19.1% | +61.3% | +21.3% | +153.6% | — |
| S&P 500 · VOO | −2.0% | −5.5% | −7.4% | −6.3% | +5.8% | +9.7% | +65.8% | +65.5% | +290.0% | — |
$54 of every $1,000 in BBP is Moderna
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | MRNAModerna | Healthcare | 5.42% | $542.22 | 35K | $6.9M |
| 2 | XERSXeris Biopharma | Healthcare | 3.44% | $344.11 | 258K | $4.4M |
| 3 | IOVAIovance Biotherapeutics | Healthcare | 2.52% | $252.12 | 430K | $3.2M |
| 4 | KNSAKiniksa Pharmaceuticals International | Healthcare | 2.52% | $251.91 | 34K | $3.2M |
| 5 | VSTMVerastem | Healthcare | 2.30% | $230.43 | 428K | $2.9M |
| 6 | OMEROmeros | Healthcare | 2.29% | $229.07 | 201K | $2.9M |
| 7 | ADMAADMA Biologics | Healthcare | 2.27% | $227.14 | 214K | $2.9M |
| 8 | REGNRegeneron Pharmaceuticals | Healthcare | 2.12% | $212.36 | 2,863 | $2.7M |
| 9 | BGNEBeOne Medicines | — | 2.10% | $209.85 | 6,628 | $2.7M |
| 10 | HALOHalozyme Therapeutics | Healthcare | 1.90% | $189.56 | 25K | $2.4M |
| 11 | RYTMRhythm Pharmaceuticals | Healthcare | 1.85% | $185.23 | 20K | $2.4M |
| 12 | GILDGilead Sciences | Healthcare | 1.85% | $185.02 | 14K | $2.4M |
| 13 | TGTXTG Therapeutics | Healthcare | 1.84% | $183.62 | 35K | $2.3M |
| 14 | IRWDIronwood Pharmaceuticals | — | 1.80% | $180.10 | 480K | $2.3M |
| 15 | ZLABZai Lab | Healthcare | 1.78% | $178.13 | 103K | $2.3M |
of the $110B in 39 Health care ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | MRNA | Moderna | 5.42% |
| 2 | XERS | Xeris Biopharma | 3.44% |
| 3 | IOVA | Iovance Biotherapeutics | 2.52% |
| 4 | KNSA | Kiniksa Pharmaceuticals International | 2.52% |
| 5 | VSTM | Verastem | 2.30% |
| 6 | OMER | Omeros | 2.29% |
| 7 | ADMA | ADMA Biologics | 2.27% |
| 8 | REGN | Regeneron Pharmaceuticals | 2.12% |
| 9 | BGNE | BeOne Medicines | 2.10% |
| 10 | HALO | Halozyme Therapeutics | 1.90% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Dec 20, 2017 | Dec 27, 2017 | $0.0723 |
| Dec 21, 2015 | Dec 29, 2015 | $0.40 |